Question · asked by 1 review

Pregabalin vs placebo: Serious adverse events

Population
patients with chronic pancreatitis and pancreatic pain
Intervention
Pregabalin
Comparison
placebo
Outcome
Serious adverse events

Pregabalin showed no clear difference in serious adverse events compared with placebo (low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Pregabalin vs placebo
Serious adverse events · patients with chronic pancreatitis and pancreatic pain
Pregabalin showed no clear difference in serious adverse events compared with placebo (low certainty).
Pregabalin for decreasing pancreatic pain in chronic pancreatitis (2016) · Cochrane Headline outcomes only
RR 1.76 [0.35, 8.96]1 study · 64 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Pregabalin for decreasing pancreatic pain in chronic pancreatitis
2016 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.